SCHEMBL7683735

SCHEMBL7683735

CN(CCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1[N+](=O)[O-])C1COC(=O)C1

nearest known ligand 0.54

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 20/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7688337 0.96 EGFR (0.54) EGFR
SCHEMBL6991313 0.89 EGFR (0.57) EGFR
SCHEMBL6988430 0.85 EGFR (0.57) EGFR
SCHEMBL1383950 0.85 EGFR (0.70) EGFR
SCHEMBL1384673 0.85 EGFR (0.70) EGFR
SCHEMBL6995705 0.85 EGFR (0.57) EGFR
SCHEMBL7690510 0.83 EGFR (0.65) EGFR
SCHEMBL6989473 0.83 EGFR (0.58) EGFR
SCHEMBL4226627 0.82 EGFR (0.57) EGFR
SCHEMBL4225530 0.82 EGFR (0.57) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403580-B1 HAVING AN INHIBITORY EFFECT ON SIGNAL TRANSDUCTION MEDIATED BY TYROSINE KINASES, THE USE THEREOF FOR TREATING DISEASES, PARTICULARLY TUMORAL DISEASES, DISEASES OF THE LUNGS AND RESPIRATORY TRACT, AND THE PREPARATION THEREOF. BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-06-11 — — US disclosed
Send feedback